• October 20, 2021  

    How an Expert Would Manage His Wife’s Metastatic Breast Cancer

    With: Richard B. Schwab, MD

    For most people with breast cancer, a lump is the first sign that leads to diagnosis. But some cases are not detected until after spread has already occurred. Here, our Curious Dr. George asks Richard B. Schwab, MD, how he would approach such a case if his own wife were the patient. Dr. Schwab is Professor of Medicine in the Division of Hematology/Oncology and… Read more »

  • October 18, 2021  

    Novel Car-T Shows ‘Promising Early Signs of Clinical Efficacy’ for Diffuse Midline Gliomas Bookmark

    George Lundberg, MD

    Healio outlines results from a Stanford University study suggesting that a type of treatment known as CAR T-cell therapy is promising for children with diffuse midline gliomas. The treatment is still in an early phase of testing in humans.

    .

  • October 18, 2021  

    Stereotactic Radiotherapy for Pancreatic Cancer: A Single-Institution Experience Bookmark

    George Lundberg, MD

    This scientific manuscript from Cureus reports results from a Toronto cancer center suggesting that stereotactic radiotherapy offers another option for palliative treatment of inoperable pancreatic cancer.

    .

  • October 18, 2021  

    Regularly Updated List of Recent FDA Approvals for Liver Cancer Bookmark

    George Lundberg, MD

    This resource from the U.S. Food and Drug Administration (FDA) lists recent drug approval announcements for liver cancer and related conditions. It also provides link to information about additional approvals that may not be announced.

    .

  • September 10, 2021  

    How an Expert Would Treat Her Own Metastatic Melanoma

    With: Pauline Funchain, MD

    Cancer patients often ask their doctors, “What would you do if you were me?” Here, our Curious Dr. George asks Cleveland Clinic oncologist Pauline Funchain, MD, how she would handle her own diagnosis of advanced melanoma. Curious Dr. George: What would you do if you personally were discovered on a routine exam to have abnormal liver function tests that led to scans and the… Read more »

  • August 16, 2021  

    The Latest in Melanoma Treatment: A Guest Perspective

    With: Ryan Sullivan, MD

    What’s new in melanoma treatment? Our chief scientist Emma Shtivelman, PhD, recently outlined the latest options. Here, our Curious Dr. George invites a response from Ryan Sullivan, MD, Associate Director of the Melanoma Program at Massachusetts General Hospital Cancer Center and Associate Professor at Harvard Medical School. Curious Dr. George: As a melanoma expert, what are your thoughts on the treatments outlined in our… Read more »

  • August 11, 2021  

    Researching More Second-Line Options for Pancreatic Cancer Bookmark

    Lola Rahib, PhD

    Article from Let’s Win! Pancreatic Cancer: A clinical trial is testing a promising treatment called eryaspase to see how well it performs as a second-line option for metastatic pancreatic cancer.

    .

  • July 28, 2021  

    New Chronic Lymphocytic Leukemia Treatments 2021 Bookmark

    George Lundberg, MD

    TheSocialMedwork outlines several new drugs for treating chronic lymphocytic leukemia, including Brukinsa (zanubrutinib).

    .

  • July 28, 2021  

    Latest Advances in the Management of Classical Hodgkin Lymphoma: The Era of Novel Therapies Bookmark

    George Lundberg, MD

    This academic review paper from Blood Cancer Journal outlines many recent advances in the treatment of Hodgkin lymphoma, including for the 15-30% of patients who do not respond or relapse after conventional treatment.

    .

  • July 28, 2021  

    New Approvals for Liver Cancer Mark ‘Golden Age’ of Treatment Bookmark

    George Lundberg, MD

    Reported in Healio: After decades of little or no progress, many new clinical trials testing targeted and immunotherapy drugs—especially in combinations—are showing that they have real value in treating primary liver cancer (hepatocellular carcinoma).

    .